Health
Scientists identify a new drug target for dry age-related macular degeneration – Medical Xpress
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. Th…
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. The study, published in the Proceedings of the National Academy of Sciences (PNAS), also holds implications for Alzheimer’s and heart disease, which are linked to vitronectin.
“Our findings suggest that vitronectin, which is shaped like a sti…
-
Business15 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
Business17 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
Business14 hours agoASX 200 mining shares rip as lithium makes a comeback
-
General22 hours agoDemocratic Republic of Congo and M23 rebel group sign new roadmap to peace in Qatar